Search Results - "Rigas, G."

Refine Results
  1. 1

    Salt sensitivity and hypertension by Balafa, Olga, Kalaitzidis, Rigas G.

    Published in Journal of human hypertension (01-03-2021)
    “…Salt sensitivity refers to the physiological trait present in mammals, including humans, by which the blood pressure (BP) of some members of the population…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations by Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G

    Published in World journal of gastroenterology : WJG (21-10-2022)
    “…The recently proposed nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease (MAFLD) has resulted…”
    Get full text
    Journal Article
  4. 4

    Prognostic Significance of Risk Factors and Biomarkers in Patients Hospitalized for Cardiorenal Syndromes: A Pilot Study by Theofilis, Panagiotis, Vordoni, Aikaterini, Nakas, Nikos, Kotsakis, Athanasios, Kranidis, Athanasios, Makryniotou, Ioanna, Kalaitzidis, Rigas G

    Published in Current medicinal chemistry (01-01-2023)
    “…Cardiorenal syndromes (CRS), involving the heart-kidney cross-talk and the activation of neurohumoral and inflammatory pathways, are an entity characterized by…”
    Get more information
    Journal Article
  5. 5

    The Role of Melatonin in Chronic Kidney Disease and Its Associated Risk Factors: A New Tool in Our Arsenal? by Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G

    Published in American journal of nephrology (01-08-2022)
    “…The increasing incidence of chronic kidney disease (CKD), as a consequence of the high prevalence of arterial hypertension and type 2 diabetes mellitus (T2DM),…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Dyslipidemia in Chronic Kidney Disease: Contemporary Concepts and Future Therapeutic Perspectives by Theofilis, Panagiotis, Vordoni, Aikaterini, Koukoulaki, Maria, Vlachopanos, Georgios, Kalaitzidis, Rigas G

    Published in American journal of nephrology (01-11-2021)
    “…Chronic kidney disease (CKD) is an increasingly prevalent disease state met with great morbidity and mortality primarily resulting from the high incidence of…”
    Get more information
    Journal Article
  8. 8

    Trimethylamine N-Oxide Levels in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis by Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G

    Published in Metabolites (09-12-2022)
    “…Non-alcoholic fatty liver disease (NAFLD) represents an entity with an increasing prevalence which is characterized by significant hepatic and extrahepatic…”
    Get full text
    Journal Article
  9. 9

    Novel therapeutic approaches in the management of chronic kidney disease: a narrative review by Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G.

    Published in Postgraduate medicine (18-08-2023)
    “…Chronic kidney disease (CKD) remains a pathologic entity with constantly rising incidence and high rates of morbidity and mortality, which are associated with…”
    Get full text
    Journal Article
  10. 10

    Hypertension is the crucial link between obstructive sleep apnea and arterial stiffness by Theofilis, Panagiotis, Kalaitzidis, Rigas G.

    “…[...]the prognostic value of the markers mentioned above may differ significantly. 7,8 Despite these marker-related limitations, the supported hypothesis has…”
    Get full text
    Journal Article
  11. 11

    Metabolic Dysfunction-Associated Fatty Liver Disease in Newly Diagnosed, Treatment-Naive Hypertensive Patients and Its Association with Cardiorenal Risk Markers by Theofilis, Panagiotis, Vordoni, Aikaterini, Tsimihodimos, Vasilis, Kalaitzidis, Rigas G

    “…Patients with arterial hypertension frequently present with comorbidities that are associated with increased cardiorenal risk, such as metabolic…”
    Get full text
    Journal Article
  12. 12

    COVID-19 and Kidney Disease: A Clinical Perspective by Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G

    Published in Current vascular pharmacology (01-01-2022)
    “…Coronavirus disease-19 (COVID-19), caused by severe acute respiratory syndrome Coronavirus- 2 (SARS-CoV-2), has caused a global pandemic with high morbidity…”
    Get more information
    Journal Article
  13. 13

    Tadalafil in patients on antihypertensive medications: Does safety remain an issue? by Theofilis, Panagiotis, Nakas, Nikos, Kalaitzidis, Rigas G.

    “…Other than its detrimental role in the quality of life of male individuals, ED is widely regarded as a risk factor associated with cardiovascular morbidity and…”
    Get full text
    Journal Article
  14. 14

    Treatment of Hypertension in Chronic Kidney Disease by Kalaitzidis, Rigas G., Elisaf, Moses S.

    Published in Current hypertension reports (01-08-2018)
    “…Purpose of Review Chronic kidney disease (CKD) is recognized as a worldwide epidemic. Hypertension commonly coexists with CKD and its prevalence is…”
    Get full text
    Journal Article
  15. 15

    Oxidative Stress Management in Cardiorenal Diseases: Focus on Novel Antidiabetic Agents, Finerenone, and Melatonin by Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G

    Published in Life (Basel, Switzerland) (20-10-2022)
    “…Oxidative stress is characterized by excessive production of reactive oxygen species together with exhausted antioxidant defenses. This constitutes a main…”
    Get full text
    Journal Article
  16. 16

    Cardiorenal syndrome and iron supplementation—more benefits than risks: a narrative review by Doumani, Georgia, Spanos, Georgios, Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G.

    Published in International urology and nephrology (01-02-2024)
    “…Intravenous iron administration has emerged as a crucial intervention for managing patients with cardiorenal syndrome (CRS) and iron deficiency, with or…”
    Get full text
    Journal Article
  17. 17

    Metabolic Dysfunction-Associated Fatty Liver Disease in the National Health and Nutrition Examination Survey 2017–2020: Epidemiology, Clinical Correlates, and the Role of Diagnostic Scores by Theofilis, Panagiotis, Vordoni, Aikaterini, Kalaitzidis, Rigas G

    Published in Metabolites (01-11-2022)
    “…The recent establishment of metabolic dysfunction-associated fatty liver disease (MAFLD) has led to a reevaluation of its epidemiology, diagnosis, and clinical…”
    Get full text
    Journal Article
  18. 18

    Endothelial Dysfunction in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis by Theofilis, Panagiotis, Vordoni, Aikaterini, Nakas, Nikolaos, Kalaitzidis, Rigas G

    Published in Life (Basel, Switzerland) (11-05-2022)
    “…Individuals with nonalcoholic fatty liver disease (NAFLD) are characterized by increased cardiovascular risk. Endothelial dysfunction, a mechanism implicated…”
    Get full text
    Journal Article
  19. 19

    Overview of infections as an etiologic factor and complication in patients with vasculitides by Theofilis, Panagiotis, Vordoni, Aikaterini, Koukoulaki, Maria, Vlachopanos, Georgios, Kalaitzidis, Rigas G.

    Published in Rheumatology international (01-05-2022)
    “…Vasculitides, a form of inflammatory autoimmune disease targeting the vessels, constitute an entity with significant morbidity and mortality. Infections have…”
    Get full text
    Journal Article
  20. 20

    Metformin-associated lactic acidosis and acute kidney injury in the era of COVID-19 by Vordoni, Aikaterini, Theofilis, Panagiotis, Vlachopanos, Georgios, Koukoulaki, Maria, Kalaitzidis, Rigas G

    Published in Frontiers in bioscience (Scholar edition) (03-12-2021)
    “…COVID-19, provoked by SARS-CoV-2, constitutes a global health issue with high rates of mortality. The presence of diabetes mellitus is associated with severe…”
    Get full text
    Journal Article